FrancophonIA/ELRC3.0 huggingface dataset:
English: • Convulsions (fits) linked to hypoglycaemia (abnormally low blood sugar levels),
Estonian: • hüpoglükeemiaga (ebanormaalselt madal veresuhkru sisaldus) seotud krambid (tõmblused);
English: 1 ml of solution contains 4.28 mg of propranolol hydrochloride equivalent to 3.75 mg of propranolol base.
Estonian: 1 ml lahust sisaldab 4,28 mg propranoloolvesinikkloriidi, mis vastab 3,75 mg propranolooli kogusele.
English: • Phaeochromocytoma
Estonian: Dihüdropüridiinid
English: Decreased appetite
Estonian: Isu langus
English: • Decreased blood pressure.
Estonian: • langenud vererõhk;
English: Decreased blood glucose
Estonian: Vähenenud vere glükoositase Vähenenud südame löögisagedus
English: • Vanilla flavour (contains propylene glycol)
Estonian: • Vanilli maitse- ja lõhnaaine (sisaldab propüleenglükooli)
English: • Do not give this medicine to your child if you are taking medicines that must not be used with
Estonian: • Ärge andke seda ravimit oma lapsele, kui võtate ravimeid, mida ei tohi koos HEMANGIOLiga kasutada (vt „Teised ravimid ja HEMANGIOL”).
English: • Citric acid monohydrate
Estonian: • Sidrunhappe monohüdraat
English: • has a slow heart rate for his/her age.
Estonian: • tal on ea kohta madal südame löögisagedus.
English: • Strawberry flavour (contains propylene glycol)
Estonian: • Maasika maitse- ja lõhnaaine (sisaldab propüleenglükooli)
English: Use with oral syringe graduated in mg of propranolol included in the package.
Estonian: Pakendis on kaasas polüpropüleenist suusüstal, mis on gradueeritud vastavalt propanolooli kogusele mg-des.
English: Lipid lowering medicinal products
Estonian: Lipiidide kontsentratsiooni langetavad ravimid
English: Somnolence
Estonian: Unehäire
English: Glucagon then catecholamines should be considered if the patient does not respond appropriately to intravenous fluid.
Estonian: Kui patsient ei reageeri sobivalt intravenoossele vedelikule, tuleb kaaluda glükagooni ja seejärel katehhoolamiinide kasutamist.
English: • is prone to low blood sugar level.
Estonian: • on soodumus madala veresuhkru tekkeks;
English: HEMANGIOL is to be given during or right after a feed to avoid the risk of hypoglycaemia.
Estonian: Hüpoglükeemia tekkimise vältimiseks tuleb HEMANGIOLi võtta söögi ajal või vahetult pärast seda.
English: A close clinical surveillance of any impaired tolerance of propranolol is requested.
Estonian: Propranolooli langenud taluvuse korral tuleb patsienti kliiniliselt jälgida.
English: Cardiovascular medicinal products
Estonian: Hüpoglükeemia ravimid
English: - Information on how to detect and manage any sign of hypoglycaemia during treatment with HEMANGIOL
Estonian: • teave preparaadi ettevalmistamise ja manustamise õige protseduuri kohta, kaasa arvatud järgmine: - juhised HEMANGIOLiga lahuse ettevalmistamise kohta; - nõuanded laste toitmise kohta ravi ajal; - teave selle kohta, kuidas tuvastada ja mida teha HEMANGIOLiga ravimise ajal tekkiva mis tahes hüpoglükeemia sümptomi korral; - juhised selle kohta, millal HEMANGIOLi manustamine katkestada;
English: Worsening of disease has been reported with beta-blockers in patients suffering from psoriasis.
Estonian: Psoriaasi põdevatel patsientidel on beetablokaatorite kasutamisel teatatud haiguse süvenemisest.
English: Important warning signs of potential side effects such as low blood pressure, low heart rate, low blood sugar level, and bronchospasm (breathing difficulties) should be looked after following administration of HEMANGIOL.
Estonian: Pärast HEMANGIOLi manustamist tuleb last jälgida oluliste sümptomite suhtes, mis võivad märku anda võimalike kõrvaltoimete nagu madala vererõhu, madala südamelöögisageduse, madala veresuhkru taseme või bronhospasmi (hingamisraskuste) tekkest.
English: Risk of hyperkaliemia
Estonian: Agranulotsütoos Hüperkaleemia
English: Give HEMANGIOL to your child
Estonian: Manustage HEMANGIOL lapsele
English: DO NOT GIVE HEMANGIOL TO YOUR CHILD UNTIL HE IS BEING CORRECTLY FED AGAIN.
Estonian: ÄRGE ANDKE OMA LAPSELE HEMANGIOLI ENNE, KUI LAPS SAAB JÄLLE PIISAVALT TOITU.
English: Hypoglycemic seizure
Estonian: • Hüdroksüetüültselluloos
English: Batch
Estonian: Vanus
English: Risks of hypoglycaemia
Estonian: Hüpoglükeemia ohud
English: Erythema Dermatitis diaper
Estonian: Müügiloa hoidja PIERRE FABRE DERMATOLOGIE
English: Cardiac disorders
Estonian: Kardiovaskulaarsed häired
English: • Hydroxyethylcellulose
Estonian: • langenud veresuhkru tase;
English: Store the bottle and oral syringe in the outer carton between each use.
Estonian: Kasutuskordade vahel hoida pudelit ja suusüstalt välispakendis.
English: If you have any further questions, ask your doctor or pharmacist.
Estonian: Kui te ei ole milleski kindel, pidage nõu oma arsti või apteekriga.
English: This leaflet was last revised in. Other sources of information
Estonian: Infoleht on viimati uuendatud.
English: • Infants prone to hypoglycaemia
Estonian: • imikud, kellel on eelsoodumus hüpoglükeemia tekkeks;
English: • Decreased blood sugar levels,
Estonian: • vere kaaliumitaseme tõus.
English: Atrioventricular blocks, intraventricular conduction delays, and congestive heart failure can occur with more severe poisoning.
Estonian: intraventrikulaarsed juhtehäired ja südamepuudulikkus;
English: What you need to know before your child receives HEMANGIOL 3.
Estonian: 1. Mis ravim on HEMANGIOL ja milleks seda kasutatakse 2. Mida on vaja teada enne, kui teie laps HEMANGIOLi võtab 3.
English: • Medicines to treat pain and inflammation,
Estonian: • valu- ja põletikuvastaseid ravimeid;
English: Peripheral coldness
Estonian: Perifeerne jahedus
English: Cardiac failure:
Estonian: Südamepuudulikkus
English: Insert the syringe
Estonian: Sisestage süstal
English: Antiarrhythmics
Estonian: Hüpoglükeemia
English: It is necessary to alert the anaesthetist to the fact that the patient is being treated with beta-blockers.
Estonian: Enne patsiendi beetablokaatoritega ravimist on oluline sellest teavitada anestesioloogi.
English: Metalloproteinase 9);
Estonian: • Prinzmetali stenokardia;
English: This summary was last updated in 06-2015.
Estonian: Kokkuvõtte viimane uuendus: 06-2015.
English: It is available as tablets (75 mg).
Estonian: Seda turustatakse tablettidena (75 mg).
English: The European Commission granted a marketing authorisation valid throughout the European Union for Clopidogrel HCS on 28 October 2010.
Estonian: Euroopa Komisjon andis ravimi Clopidogrel HCS müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, 28. oktoobril 2010.
English: The full EPAR for Clopidogrel HCS can be found on the Agency's website: EMA website/Find medicine/Human medicines/European Public Assessment Reports.
Estonian: Euroopa avaliku hindamisaruande täistekst ravimi Clopidogrel HCS kohta on ameti veebilehel: EMA website/Find medicine/Human medicines/European Public Assessment Reports.
English: The standard dose of Clopidogrel HCS is one 75-mg tablet once a day.
Estonian: Ravimi Clopidogrel HCS standardannus on üks 75 mg tablett üks kord ööpäevas.
English: This is then followed by the standard 75mg dose once a day for at least four weeks (in ST segment elevation myocardial infarction) or for up to 12 months (in unstable angina or non-Q-wave myocardial infarction).
Estonian: Seejärel jätkatakse standardannusega 75 mg ööpäevas vähemalt 4 nädalat (ST-segmendi elevatsiooniga infarkti korral) või kuni 12 kuud (ebastabiilse stenokardia või Q-sakita südameinfarkti korral).
English: For more information on generic medicines, see the question-and-answer document here.
Estonian: Lisateave geneeriliste ravimite kohta on teabedokumendis siin
English: It is used in patients who have at least one risk factor for events such as a heart attack or stroke, cannot take vitamin-K antagonists (other medicines that prevent blood clots) and are at low risk of bleeding.
Estonian: Ravimit kasutatakse patsientidel, kellel on vähemalt üks vaskulaarhäirete, näiteks südameinfarkti või insuldi riskitegur, kes ei saa võtta K-vitamiini antagoniste (samuti vere hüübimist takistavad ravimid) ja kellel on väike verejooksurisk.
English: In acute coronary syndrome and atrial fibrillation, Clopidogrel HCS is used together with aspirin, the dose of which should not be higher than 100 mg.
Estonian: Ägeda koronaarsündroomi ja kodade virvenduse korral võetakse ravimit Clopidogrel HCS koos aspiriiniga, mille annus ei tohi ületada 100 mg.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Clopidogrel HCS.
Estonian: Selles selgitatakse, kuidas inimravimite komitee hindas ravimit ja otsustas toetada müügiloa andmist; samuti esitatakse komitee soovitused, kuidas ravimit kasutada.
English: Clopidogrel HCS can be started between seven days and six months after the stroke;
Estonian: Ravimi Clopidogrel HCS manustamist tohib alustada 7 päeva kuni 6 kuu jooksul pärast insulti.
English: For more information about treatment with Clopidogrel HCS, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate ravimiga Clopidogrel HCS toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.
English: The Committee recommended that Clopidogrel HCS be given marketing authorisation.
Estonian: Komitee soovitas anda ravimi Clopidogrel HCS müügiloa.
English: This is a summary of the European public assessment report (EPAR) for Clopidogrel HCS.
Estonian: See on ravimi Clopidogrel HCS Euroopa avaliku hindamisaruande kokkuvõte.
English: Clopidogrel HCS can be used in patients who are having a heart attack with ‘ST segment elevation' (an abnormal reading on the ECG or electrocardiogram) when the doctor thinks that they would benefit from the treatment.
Estonian: Ravimit Clopidogrel HCS tohivad võtta ka patsiendid, kellel on ST-segmendi elevatsiooniga (elektrokardiogrammi ehk EKG teatud ebanormaalne näit) südameinfarkt, kui arst arvab, et ravim on patsiendile kasulik.
English: Because Clopidogrel HCS is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as those of the reference medicine's.
Estonian: Et Clopidogrel HCS on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
English: • patients with peripheral arterial disease (problems with blood flow in the arteries);
Estonian: • Perifeersete arterite haigusega (arteriaalsete verevarustushäiretega) patsiendid.
English: This means that Clopidogrel HCS is similar to a ‘reference medicine' already authorised in the European Union (EU) called Plavix.
Estonian: See tähendab, et Clopidogrel HCS on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
English: It can also be used in patients who do not have this abnormal reading on the ECG, if they have unstable angina (a severe type of chest pain) or have had a ‘non-Q-wave' myocardial infarction.
Estonian: Samuti tohib ravimit kasutada patsientidel, kellel seda ebanormaalset EKG-näitu ei ole, kui neil on ebastabiilne stenokardia (tugevad rindkerevalud) või on olnud Q-sakita südameinfarkt.
English: The CHMP concluded that, in accordance with EU requirements, Clopidogrel HCS has been shown to have comparable quality and to be bioequivalent to Plavix.
Estonian: Inimravimite komitee järeldas, et vastavalt Euroopa Liidu nõuetele on tõendatud ravimi Clopidogrel HCS võrreldav kvaliteet ja bioekvivalentsus ravimiga Plavix.
English: • patients who have recently had a myocardial infarction (heart attack).
Estonian: • Patsiendid, kellel on hiljuti olnud südameinfarkt.
English: Clopidogrel HCS can be given to the following groups of patients:
Estonian: Ravimit Clopidogrel HCS tohib kasutada järgmiste patsiendirühmade ravimiseks.
English: Clopidogrel HCS can be started between a few days and 35 days after the attack;
Estonian: Ravimi Clopidogrel HCS manustamist tohib alustada mõne kuni 35 päeva jooksul pärast infarkti.
English: • patients with atrial fibrillation (irregular rapid contractions of the upper chambers of the heart), when it should be given with aspirin.
Estonian: • Patsiendid, kellel on kodade virvendus (südamekodade korrapäratu kiire kokkutõmbumine), mille korral tuleb ravimit kasutada koos aspiriiniga.
English: Therefore, the CHMP's view was that, as for Plavix, the benefit outweighs the identified risk.
Estonian: Seetõttu arvas inimravimite komitee, et nagu ka Plavixi korral, ületab ravimi Clopidogrel HCS kasulikkus sellega kaasnevad riskid.
English: Because Clopidogrel HCS is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Plavix.
Estonian: Et Clopidogrel HCS on geneeriline ravim, piirdusid patsiendiuuringud katsetega, milles näidati ravimi Clopidogrel HCS bioekvivalentsust võrdlusravimiga Plavix.
English: Clopidogrel HCS is a blood-thinning medicine that contains the active substance clopidogrel.
Estonian: Clopidogrel HCS on ravim, mis sisaldab toimeainena klopidogreeli.
English: Clopidogrel HCS is used in adults to prevent problems caused by blood clots.
Estonian: Ravimit Clopidogrel HCS kasutatakse trombidest (soonesisestest verehüüvetest) põhjustatud probleemide ennetamiseks täiskasvanutel.
English: When the blood clots, this is due to special cells in the blood called platelets aggregating (sticking together).
Estonian: Veri hüübib teatud vererakkude - trombotsüütide (vereliistakute) - agregatsiooni (kokkukleepumise) tõttu.
English: Clopidogrel HCS is a ‘generic medicine'.
Estonian: Clopidogrel HCS on geneeriline ravim.
English: • patients who have had a recent ischaemic stroke (stroke caused by failure of the blood supply to part of the brain).
Estonian: • Patsiendid, kellel on hiljuti olnud isheemiline insult (teatud ajuosa verevarustushäiretest tingitud insult).
English: What is Clopidogrel HCS?
Estonian: Mis on Clopidogrel HCS?
English: Other information about Clopidogrel HCS
Estonian: Muu teave ravimi Clopidogrel HCS kohta
English: Why has Clopidogrel HCS been approved?
Estonian: Miks Clopidogrel HCS heaks kiideti?
English: How has Clopidogrel HCS been studied?
Estonian: Kuidas ravimit Clopidogrel HCS uuriti?
English: What are the benefits and risks of Clopidogrel HCS?
Estonian: Milles seisneb ravimi Clopidogrel HCS kasulikkus ja mis riskid ravimiga kaasnevad?
English: How does Clopidogrel HCS work?
Estonian: Kuidas Clopidogrel HCS toimib?
English: The active substance in Clopidogrel HCS, clopidogrel, is an inhibitor of platelet aggregation.
Estonian: Clopidogrel HCSi toimeaine klopidogreel on trombotsüütide agregatsiooni (vereliistakute kokkukleepumise) inhibiitor, mis aitab ennetada trombide (soonesiseste verehüüvete) tekkimist.
English: How is Clopidogrel HCS used?
Estonian: Kuidas ravimit Clopidogrel HCS kasutatakse?
English: • patients with acute coronary syndrome (a condition in which blood supply to the heart is reduced), when it should be given with aspirin (another medicine that prevents blood clots), including patients who have had a stent inserted (a short tube placed in an artery to prevent it closing up).
Estonian: Sel juhul tuleb ravimit Clopidogrel HCS kasutada koos aspiriiniga (samuti antikoagulant), ka patsientidele, kellele on paigaldatud stent (ahenenud arterit avardav väike toru).
English: What is Clopidogrel HCS used for?
Estonian: Milleks ravimit Clopidogrel HCS kasutatakse?
English: List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the member states for tetrazepam-containing medicinal product(s)
Estonian: LISA I RAVIMITE NIMETUSTE, RAVIMVORMIDE, MEDITSIINITOODETE TUGEVUSTE, MANUSTAMISVIISIDE, MÜÜGILOA HOIDJATE LOETELU LIIKMESRIIKIDES
English: Str. Victor Babeş nr. 50, Baia Mare Jud.
Estonian: Str. Victor Babeş nr. 50, Baia Mare
English: Coated tablet
Estonian: Kaetud tablett
English: 85101 Bratislava
Estonian: 85101 Bratislava Slovak Republic
English: Chephasaar Chemisch- Pharmazeutische Fabrik GmbH
Estonian: Chephasaar ChemischPharmazeutische Fabrik GmbH
English: S.C. A.C. Helcor Pharma S.R.L.
Estonian: Helcor Pharma S.R.L.
English: UAB “Sanofi-Aventis Lietuva” A. Juozapavičiaus g. 6/2 LT-09310 Vilnius Lithuania
Estonian: A. Juozapavičiaus g. 6/2 LT-09310 Vilnius Lithuania
English: Daiichi Sankyo France SAS Immeuble le Corosa 1, rue Eugene et Armand Peugeot 92508 Rueil Malmaison France
Estonian: Daiichi Sankyo France SAS Immeuble le Corosa 1, rue Eugene et Armand Peugeot
English: Praha 6 - Vokovice, 160 00
Estonian: Evropská 846/176a Praha 6 - Vokovice, 160 00 Czech Republic
English: Ranbaxy Pharmacie Generiques 11-15 Quai Dion Bouton 92816 Puteaux
Estonian: 11-15 Quai Dion Bouton 92816 Puteaux France
English: Sanofi Aventis France 1-13, boulevard Romain Rolland 75014 Paris
Estonian: Sanofi Aventis France 1-13, boulevard Romain Rolland
English: Belgium Eurogenerics NV Heizel Esplanade b22
Estonian: Eurogenerics NV Heizel Esplanade b22 1020 Brussel Belgium
English: EG Labo - Laboratoires Eurogenerics "Le Quintet" - bâtiment A 12, rue Danjou
Estonian: EG Labo - Laboratoires Eurogenerics "Le Quintet" - bâtiment A 12, rue Danjou 92517 Boulogne Billancourt Cedex
English: Slovak Republic Sanofi-Aventis Slovakia s.r.o.
Estonian: Sanofi-Aventis Slovakia s.r.o.
English: Belgium Will Pharma S.A. Monplaisirlaan 33
Estonian: Will Pharma S.A. Monplaisirlaan 33 B-1030 Brussel Belgium
English: 110, Esplanade du Général de Gaulle 92931 Paris La Défense Cedex France
Estonian: 92931 Paris La Défense Cedex
English: Belgium Sanofi Aventis Belgium N.V Culliganlaan 1C
Estonian: Sanofi Aventis Belgium N.V Culliganlaan 1C 1831 Diegem
English: Czech Republic Sanofi-Aventis, s.r.o.
Estonian: Sanofi-Aventis, s.r.o.
English: 49, avenue Georges Pompidou 92300 Levallois-Perret France
Estonian: 92300 Levallois-Perret France
English: 25, rue des Peupliers ZAC Les Hautes Pâtures - Parc d'Activités des Peupliers 923752 Nanterre France
Estonian: Zydus France 25, rue des Peupliers ZAC Les Hautes PâturesParc d'Activités des Peupliers
English: 15, boulevard Charles de Gaulle 92700 Colombes France
Estonian: 15, boulevard Charles de Gaulle
English: ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
Estonian: Poola ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
English: Sandoz Pharmaceuticals GmbH Raiffeisenstr.
Estonian: Sandoz Pharmaceuticals GmbH
English: MIP Pharma GmbH Kirkeler Straße 41
Estonian: MIP Pharma GmbH Kirkeler Straße 41 D-66440 BlieskastelNiederwürzbach Germany
English: 58-500, Jelenia Góra, Poland
Estonian: Przedsiębiorstwo Farmaceutyczne Jelfa S.A. Wincentego st. Pola 21 58-500, Jelenia Góra, Poland
English: Sanofi-Aventis Deutschland GmbH Industriepark Höchst, Gebäude K703 65926 Frankfurt am Main Germany
Estonian: Industriepark Höchst, Gebäude K703
English: Tetrazepamneuraxpharm 100 mg neuraxpharm Arzneimittel GmbH Elisabeth-Selbert-Str. 23 40764 Langenfeld Germany
Estonian: Elisabeth-Selbert-Str. 23 40764 Langenfeld Germany
English: Tetramdura 50mg 50 mg neuraxpharm Arzneimittel GmbH Elisabeth-Selbert-Str. 23 40764 Langenfeld Germany
Estonian: Tetramdura 50mg 50 mg neuraxpharm Arzneimittel GmbH
English: Tetrazepam KSK 50 mg
Estonian: Tetrazepam KSK
English: România
Estonian: Maramureş România
English: Lithuania
Estonian: Poola
English: 22 October 2009
Estonian: 20. aprill 2011
English: Outcome of a procedure under Article 31 of Directive 2001/83/EC as amended
Estonian: Muudetud direktiivi 2001/83/EÜ artikli 31 kohase menetluse tulemused
English: EMA/459105/2010 EMEA/H/A-31/1232
Estonian: EMA/728909/2010 rev.1 EMEA/H/A-31/1232
English: Why were these medicines reviewed?
Estonian: Miks nende ravimite andmed läbi vaadati?
English: • Patients who have any questions should speak to their doctor or pharmacist.
Estonian: • Patsiendid, kellel on mis tahes küsimusi, peavad pöörduma oma arsti või apteekri poole.
English: See: http://www.who.int/cancer/palliative/painladder/en/.
Estonian: Vt http://www.who.int/cancer/palliative/painladder/en/.
English: Some information was also available from studies in human volunteers.
Estonian: Mõnel määral saadi teavet ka vabatahtlike uuringutest.
English: The full changes made to the information to doctors and patients are detailed here.
Estonian: Täielik ülevaade arstidele ja patsientidele ettenähtud teabes tehtud muudatustest on siin.
English: They looked at seven different systems used with morphine, two used with hydromorphone and four used with oxycodone.
Estonian: Uuriti seitset eri süsteemi, milles kasutati morfiini, kaht hüdromorfooni ja nelja oksükodooni kasutatavat süsteemi.
English: For all other medicines in this class, the Committee concluded that their benefits continue to outweigh their risks, and therefore recommended that their marketing authorisations be maintained.
Estonian: Kõikide muude sama klassi ravimite kohta leidis komitee, et nende kasulikkus on endiselt suurem kui riskid, ning soovitas seetõttu nende müügiload säilitada.
English: When these capsules were put into a 20% alcohol solution, 80% of the active substance was released within 15 minutes.
Estonian: Kapslid pandi 20% alkoholilahusesse, misjärel vabanes 80% toimeainest 15 minutiga.
English: • Prescribers of modified-release opioids and their patients should be aware of the potential interaction between these medicines and alcohol.
Estonian: • Toimeainet modifitseeritult vabastavaid opioide määravad arstid ning nende patsiendid peavad olema teadlikud kõnealuste ravimite ja alkoholi võimalikust koostoimest.
English: These are called ‘controlled-release systems'.
Estonian: Neid nimetatakse toimeaine vabanemist reguleerivateks süsteemideks.
English: They should take note of the restrictions and warnings for the medicines that they are using.
Estonian: Arvesse tuleb võtta ravimi kohta kehtivaid hoiatusi ja piiranguid.
English: Consequently, the European Commission asked the CHMP to carry out an assessment of the benefitrisk balance of these medicines, concentrating on their interaction with alcohol, and to issue an opinion on whether their marketing authorisations should be maintained, varied, suspended or withdrawn across the EU.
Estonian: Sellest tulenevalt palus Euroopa Komisjon inimravimite komiteel hinnata kõnealuste ravimite kasulikkuse ja riski suhet, keskendudes ravimite koostoimele alkoholiga, ning avaldada arvamust, kas nende ravimite müügiload tuleb kogu ELis säilitada, muuta, peatada või tagasi võtta .
English: • Prescribers are reminded that there are a large number of modified-release opioids available in each Member State.
Estonian: • Ravimeid määravad arstid peavad teadma, et igas liikmesriigis turustatakse paljusid toimeainet modifitseeritult vabastavaid opioide.
English: However, studies looking at the drinking behaviour of patients with severe pain show that many patients drink alcohol while being treated with strong opioids.
Estonian: Samas näitavad tugeva valu all kannatavate patsientide alkoholitarbimist käsitlevad uuringud, et paljud patsiendid joovad tugevatoimeliste opioidide tarvitamise ajal alkoholi.
English: Oral opioid medicines of the WHO level III scale for the management of pain are strong painkillers that are taken by mouth and used to treat intense pain that has not been controlled sufficiently with other medicines.
Estonian: WHO valuvaigistamise skaala III astmel kasutatavad suukaudsed opioidravimid on tugevatoimelised valuvaigistid, mida manustatakse suu kaudu ning millega ravitakse intensiivset valu, mida muud ravimid ei ole piisavalt leevendanud.
English: These included patients with late-stage cancer.
Estonian: Need uuringud hõlmasid kaugelearenenud vähiga patsiente.
English: Therefore, the Committee recommended that the warnings on this interaction be made consistent in the information for doctors and patients across all oral opioid medicines of the WHO level III scale.
Estonian: Seepärast soovitas komitee ühtlustada arstidele ja patsientidele suunatud teabes hoiatusi sellise koostoime kohta kõikide suukaudsete WHO skaala III astme opioidravimite korral.